Abstract
Purpose
The clinical significance of lymph node micrometastasis (LNMM) remains controversial in gastric cancer (GC). In this study, we investigated the prognostic impact of LNMM in patients with GC.
Methods
A total of 624 patients with pathologically lymph node metastasis-negative (pN0) and N1 status (pN1) who underwent gastrectomy between 2004 and 2018 were enrolled in this retrospective study. The diameter of tumor cell clusters in metastatic lymph nodes was measured in 120 patients with pN1 GC.
Results
Patients with lymph node tumors < 1500 μm in diameter (LNMM) had a significantly better prognosis than those with tumors ≥ 1500 μm in diameter (p = 0.012; log-rank test). Cox’s proportional hazards model revealed that LNMM (p = 0.016), several dissected lymph nodes (p = 0.049), and the provision of adjuvant chemotherapy (p = 0.002) were independent prognostic factors for the overall survival of patients with pN1 GC. There was no significant difference in the overall survival between patients with LNMM who received chemotherapy and those who did not (p = 0.332).
Conclusions
LNMM is associated with a favorable prognosis and maybe an independent prognostic marker in patients with pN1 GC. LNMM in GC may be considered a factor preventing adjuvant chemotherapy.
Similar content being viewed by others
Data availability
All data generated or analyzed during this article are included in this published article. The data that support the findings of this study are available from the corresponding author, upon reasonable request.
References
Zhou J, Chen Q. Poor expression of microRNA-135b results in the inhibition of cisplatin resistance and proliferation and induces the apoptosis of gastric cancer cells through MST1-mediated MAPK signaling pathway. FASEB J. 2019;33:3420–36.
Kodama Y, Sugimachi K, Soejima K, Matsusaka T, Inokuchi K. Evaluation of extensive lymph node dissection for carcinoma of the stomach. World J Surg. 1981;5:241–8.
Ohgaki M, Toshio T, Akeo H, Yamasaki J, Togawa T. Effect of extensive lymph node dissection on the survival of early gastric cancer. Hepatogastroenterology. 1999;46:2096–9.
Otsuji E, Kuriu Y, Ichikawa D, Okamoto K, Hagiwara A, Yamagishi H. Tumor recurrence and its timing following curative resection of early gastric carcinoma. Anticancer Res. 2003;23:3499–503.
Maehara Y, Okuyama T, Moriguchi S, Orita H, Kusumoto H, Korenaga D, et al. Prophylactic lymph node dissection in patients with advanced gastric cancer promotes increased survival time. Cancer. 1992;70:392–5.
Japanese gastric cancer treatment guidelines 2018. (5th ed.). Gastric Cancer. 2020.
Sobin LH, Gospodarowicz MK, Wittekind C. International Union against cancer. TNM classification of malignant tumours Chichester West Sussex. Wiley-Blackwell; 2010.
Zhou Y, Zhang GJ, Wang J, Zheng KY, Fu W. Current status of lymph node micrometastasis in gastric cancer. Oncotarget. 2017;8:51963–9.
Lee E, Chae Y, Kim I, Choi J, Yeom B, Leong AS-Y. Prognostic relevance of immunohistochemically detected lymph node micrometastasis in patients with gastric carcinoma. Cancer. 2002;94:2867–73.
Yasuda K, Adachi Y, Shiraishi N, Inomata M, Takeuchi H, Kitano S. Prognostic effect of lymph node micrometastasis in patients with histologically node-negative gastric cancer. Ann Surg Oncol. 2002;9:771–4.
Eguchi T, Kodera Y, Nakanishi H, Yokoyama H, Ohashi N, Ito Y, et al. The effect of chemotherapy against micrometastases and isolated tumor cells in lymph nodes: an in vivo study. Vivo. 2008;22:707–12.
Williams JR. The ethics activities of the World Medical Association. Sci Eng Ethics. 2005;11:7–12.
Japanese classification of gastric carcinoma (3rd English ed.). Gastric Cancer. 2011;14:101–12.
Fujiwara Y, Okada K, Hanada H, Tamura S, Kimura Y, Fujita J, et al. The clinical importance of a transcription reverse-transcription concerted (TRC) diagnosis using peritoneal lavage fluids in gastric cancer with clinical serosal invasion: a prospective, multicenter study. Surgery. 2014;3:417–23.
Yaguchi Y, Sugasawa H, Tsujimoto H, Takata H, Nakabayashi K, Ichikura T, et al. One-step nucleic acid amplification (OSNA) for the application of sentinel node concept in gastric cancer. Am Surg Oncol. 2011;8:2289.
Natsugoe S, Arigami T, Uenosono Y, Yanagita S. Novel surgical approach based on the sentinel node concept in patients with early gastric cancer. Ann Gastroenterol Surg. 2017;1:180–5.
Wang J, Yu JC, Kang WM, Wang WZ, Liu YQ, Gu P. The predictive effect of cadherin-17 on lymph node micrometastasis in pN0 gastric cancer. Ann Surg Oncol. 2012;19:1529–34.
Kim JJ, Song KY, Hur H, Hur JI, Park SM, Park CH. Lymph node micrometastasis in node negative early gastric cancer. Eur J Surg Oncol. 2009;35:409–14.
Morgagni P, Saragoni L, Scarpi E, Zattini PS, Zaccaroni A, Morgagni D, et al. Lymph node micrometastases in early gastric cancer and their impact on prognosis. World J Surg. 2003;27:558–61.
Ito S, Ohashi Y, Sasako M. Survival after recurrence in patients with gastric cancer who receive S-1 adjuvant chemotherapy: exploratory analysis of the ACTS-GC trial. BMC Cancer. 2018;18:449.
Kim YJ, Chung WC, Youn GJ, Jun KH, Chin HM. The predictive factors of gastric cancer recurrence after the completion of adjuvant chemotherapy in advanced gastric cancer. Rev Esp Enferm Dig. 2019;111:537–42.
Xu X, Zheng G, Zhang T, Zhao Y, Zheng Z. Is pathologic tumor regression grade after neo-adjuvant chemotherapy a promising prognostic indicator for patients with locally advanced gastric cancer? A cohort study evaluating tumor regression response. Cancer Chemother Pharmacol. 2019;84:635–46.
Saka M, Katai H, Fukagawa T, Nijjar R, Sano T. Recurrence in early gastric cancer with lymph node metastasis. Gastric Cancer. 2008;11:214–8.
Uchida M, Kondo Y, Suzuki S, Hosohata K. Evaluation of acute kidney injury associated with anticancer drugs used in gastric cancer in the Japanese adverse drug event report database. Ann Pharmacother. 2019;53:1200–6.
Acknowledgements
Not applicable.
Funding
The authors declare that they have no funding.
Author information
Authors and Affiliations
Contributions
AY and KS designed the research. KS performed the research. KS reviewed the surgical pathology. AY and KS analyzed the data. AY and KS wrote the paper. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflicts of interest
None of the authors have any conflicts of interest to disclose.
Ethics approval
This study was approved by the Ethics Committee of the University of Yamanashi Hospital and was performed in accordance with the ethical standards of the Declaration of Helsinki and its later amendments.
Informed consent
Informed consent was obtained from the patient for the publication of these findings and accompanying images.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Yamamoto, A., Shoda, K., Kawaguchi, Y. et al. Prognostic impact of lymph node micrometastasis in patients with gastric cancer. Surg Today 52, 61–68 (2022). https://doi.org/10.1007/s00595-021-02302-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00595-021-02302-9